Functional and Genetic Diversity in the Concentrative Nucleoside Transporter, CNT1, in Human Populations

Molecular Pharmacology

Volumn 65, Issue 3, 2004, Pages 512-519

  Gray, Jennifer H ^a   Mangravite, Lara M ^a   Owen, Ryan P ^a   Urban, Thomas J ^a   Chan, Wendy ^a   Carlson, Elaine J ^a   Huang, Conrad C ^a   Kawamoto, Michiko ^a   Johns, Susan J ^a   Stryke, Douglas ^a   Ferrin, Thomas E ^a   Giacomini, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 1; GEMCITABINE; NUCLEOSIDE ANALOG; NUCLEOSIDE TRANSPORTER; PROLINE; PYRIMIDINE NUCLEOSIDE; SERINE; THYMIDINE; UNCLASSIFIED DRUG; VALINE;

AFRICAN AMERICAN; ARTICLE; ASIAN; BASE PAIRING; BINDING AFFINITY; DRUG DISPOSITION; DRUG UPTAKE; EUROPEAN AMERICAN; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE INSERTION; GENETIC VARIABILITY; HAPLOTYPE; HISPANIC; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PACIFIC ISLANDS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; BIOLOGICAL TRANSPORT; DNA, COMPLEMENTARY; HAPLOTYPES; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEOSIDE TRANSPORT PROTEINS; PROTEIN STRUCTURE, SECONDARY; VARIATION (GENETICS);

EID: 10744229920     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.65.3.512     Document Type: Article

References (32)

1. Abbruzzese JL (2002) New applications of gemcitabine and future directions in the management of pancreatic cancer. Cancer 95:941-945.
2. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, et al. (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413.
3. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238.
4. Cordes FS, Bright JN, and Sansom MS (2002) Proline-induced distortions of transmembrane helices. J Mol Biol 323:951-960.
5. Dresser MJ, Leabman MK, and Giacomini KM (2001) Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 90:397-421.
6. Duflot S, Calvo M, Casado FJ, Enrich C, and Pastor-Anglada M (2002) Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway. Exp Cell Res 281:77-85.
7. Fay JC, Wyckoff GJ, and Wu CI (2001) Positive and negative selection on the human genome. Genetics 158:1227-1234.
8. Gray JH, Owen RP, and Giacomini KM (2003) The concentrative nucleoside transporter family, SLC28. Pfluegers Arch Eur J Physiol 2003 Jul 11 [Epub ahead of print].
9. Grunewald R, Kantarjian H, Du M, Faucher K, Tarassoff P, and Plunkett W (1992) Gemcitabine in leukemia: a phase I clinical, plasma and cellular pharmacology study. J Clin Oncol 10:406-413.
10. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, and Chakravarti A (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247.
11. +-nucleoside cotransporter rCNT1. J Biol Chem 276:27981-8.
12. Hartl DL and Clark AG (1997) Principles of Population Genetics. Sinauer Associates, Sunderland, MA.
13. Jegla T and Salkoff L (1997) A novel subunit for shal K+ channels radically alters activation and inactivation. J Neurosci 17:32-44.
14. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, et al. (2003) Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci USA 100:5896-5901.
15. + nucleoside cotransporters hCNT1 and hCNT2. J Biol Chem 274:24475-84.
16. Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA, Crawford CR, and Cass CE (1998) Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 58:4349-4357.
17. Mangravite LM, Badagnani I and Giacomini KM (2003) Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol 479:269-281.
18. Mangravite LM, Lipschutz JH, Mostov KE, and Giacomini KM (2001) Localization of GFP-tagged concentrative nucleoside transporters in a renal polarized epithelial cell line. Am J Physiol 280:F879-F885.
19. Miller MP and Kumar S (2001) Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10:2319-2328.
20. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, Ferrin TE, Herskowitz I, and Giacomini KM (2003) Functional characterization in yeast of genetic variants in the human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 13:297-301.
21. Povlock SL and Amara SG (1998) Vaccinia virus-T7 RNA polymerase expression system for neurotransmitter transporters. Methods Enzymol 296:436-443.
22. +-nucleoside cotransporter (hCNT1). Am J Physiol 272:C707-C714.
23. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (Lond) 409:928-933.
24. Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, et al. (2003) Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci USA 100:5902-5907.
25. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, et al. (2001a) Haplotype variation and linkage disequilibrium in 313 human genes. Science (Wash DC) 293:489-493.
26. Stephens M, Smith NJ, and Donnelly P (2001b) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
27. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595.
28. Tempero M, Plunkett W, Ruiz Van Haperen V, Hainsworth J, Hochster H, Lenzi R, and Abbruzzese J (2003) Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. J Clin Oncol 21:3402-3408.
29. +-dependent nucleoside transporters. J Biol Chem 272:28845-28848.
30. +-nucleoside transporter. J Biol Chem 274:2298-2302.
31. +-coupled electrogenic lysosomal amino acid transporter LYAAT1 localizes to the axon and plasma membrane of hippocampal neurons. J Neurosci 23:1265-1275.
32. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, and Giacomini KM (1997) Cloning and functional expression of a human liver organic cation transporter. Mol Pharmacol 51:913-921.